Literature DB >> 24690197

Overt hypothyroidism is associated with the presence of uterine leiomyoma: a retrospective analysis.

Johannes Ott1, Christine Kurz1, Ronald Braun1, Regina Promberger2, Rudolf Seemann3, Elisabeth Vytiska-Binstorfer1, Katharina Walch4.   

Abstract

OBJECTIVE: A possible correlation between uterine leiomyoma and thyroid disease was reported decades ago. We aimed to evaluate the possible associations between the presence of uterine leiomyomas and (i) the presence of overt hypothyroidism, (ii) the level of anti-thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (TG-Ab), and (iii) thyroid stimulating hormone (TSH) levels. STUDY
DESIGN: In a retrospective study, all 215 sterile women who underwent reproductive surgery (hysteroscopy and laparoscopy/laparotomy) at our department from January 2007 to January 2011 were included. All leiomyomas suspected on gynecologic ultrasound were verified during surgery. As risk factors for uterine leiomyomas, thyroid parameters, age, African heritage, age at menarche, parity, and body mass index were included.
RESULTS: One or more uterine leiomyomas were found in 51 cases (23.7%). After multivariate analysis, three parameters remained significant, with African heritage the most important (odds ratio, OR, 27.80), followed by overt hypothyroidism (OR 3.10) and increasing age (OR 1.23). Larger leiomyomas were found in women with overt hypothyroidism than in those without overt hypothyroidism (median, 70 mm; range, 5-88 vs. median, 30 mm; range, 2-93, respectively; p=0.007).
CONCLUSIONS: Overt hypothyroidism, but not autoantibodies against the thyroid gland, was associated with the presence of uterine leiomyoma in our study.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune thyroiditis; Hypothyroidism; Risk factors; Sterility; Uterine leiomyoma

Mesh:

Substances:

Year:  2014        PMID: 24690197     DOI: 10.1016/j.ejogrb.2014.03.003

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Subtle changes in menstrual cycle function-Pieces of the puzzle.

Authors:  Sunni L Mumford; Keewan Kim
Journal:  Paediatr Perinat Epidemiol       Date:  2018-04-16       Impact factor: 3.980

Review 2.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

3.  Maternal and Paternal Infertility Disorders and Treatments and Autism Spectrum Disorder: Findings from the Study to Explore Early Development.

Authors:  Laura A Schieve; Carolyn Drews-Botsch; Shericka Harris; Craig Newschaffer; Julie Daniels; Carolyn DiGuiseppi; Lisa A Croen; Gayle C Windham
Journal:  J Autism Dev Disord       Date:  2017-12

4.  A multi-stage genome-wide association study of uterine fibroids in African Americans.

Authors:  Jacklyn N Hellwege; Janina M Jeff; Lauren A Wise; C Scott Gallagher; Melissa Wellons; Katherine E Hartmann; Sarah F Jones; Eric S Torstenson; Scott Dickinson; Edward A Ruiz-Narváez; Nadin Rohland; Alexander Allen; David Reich; Arti Tandon; Bogdan Pasaniuc; Nicholas Mancuso; Hae Kyung Im; David A Hinds; Julie R Palmer; Lynn Rosenberg; Joshua C Denny; Dan M Roden; Elizabeth A Stewart; Cynthia C Morton; Eimear E Kenny; Todd L Edwards; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2017-08-23       Impact factor: 5.881

5.  Uterine fibroids increase the risk of thyroid goiter and thyroid nodules.

Authors:  Jin-Sung Yuk; Jung Min Kim
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

6.  Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.

Authors:  Hanna-Riikka Heinonen; Annukka Pasanen; Oskari Heikinheimo; Tomas Tanskanen; Kimmo Palin; Jaana Tolvanen; Pia Vahteristo; Jari Sjöberg; Esa Pitkänen; Ralf Bützow; Netta Mäkinen; Lauri A Aaltonen
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.